CIK 0001377121 · Large accelerated filer
Protagonist Therapeutics, Inc
Sign in to watch- Ticker
- PTGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980505495
- Phone
- (510) 474-0170
- Business address
- 7707 GATEWAY BLVD., SUITE 140, NEWARK, CA, 94560-1160
- Former names
- Protagonist Therapeutics Inc, Protagonist Inc
- 4 Option exercise Director acquired 12,000 shares (option exercise)
- 4 Option exercise President and CEO acquired 15,742 shares (option exercise)
- 8-K Event Results of operations
- 4 Option exercise Chief Development Officer acquired 40,000 shares (option exercise)
- 4 Option exercise President and CEO acquired 30,000 shares (option exercise)
- 8-K Event Regulation FD disclosure
- 4 Grant or award Chief Financial Officer acquired 13,750 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Option exercise President and CEO acquired 34,087 shares (option exercise)
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 8-K Event Other events
- 8-K Event Executive or director change
- 8-K Event Executive or director change
- 4 Shares withheld for taxes Chief Development Officer gave up 649 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 4,648 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 2,119 shares (to pay taxes)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations
Page 17 of 36 · 707 filings